Analysis Metabolite Name Measured Value Units Sample Treatment
Reversed phase NEGATIVE ION MODEpyridoxamine0.1622Peak areaFeces Saline
Reversed phase NEGATIVE ION MODEpyridoxamine0.2213Peak areaFeces Angiotensin II
Reversed phase NEGATIVE ION MODEpyridoxamine0.3420Peak areaFeces Angiotensin II
Reversed phase NEGATIVE ION MODEpyridoxamine0.5268Peak areaFeces Saline
Reversed phase NEGATIVE ION MODEpyridoxamine0.5472Peak areaFeces Angiotensin II
Reversed phase NEGATIVE ION MODEpyridoxamine0.5634Peak areaFeces Saline
Reversed phase NEGATIVE ION MODEpyridoxamine0.6234Peak areaFeces Saline
Reversed phase NEGATIVE ION MODEpyridoxamine0.6341Peak areaFeces Saline
Reversed phase NEGATIVE ION MODEpyridoxamine0.6620Peak areaFeces Saline
Reversed phase NEGATIVE ION MODEpyridoxamine0.6643Peak areaFeces Angiotensin II
Reversed phase NEGATIVE ION MODEpyridoxamine0.6699Peak areaFeces Angiotensin II
Reversed phase NEGATIVE ION MODEpyridoxamine0.6803Peak areaFeces Angiotensin II
Reversed phase NEGATIVE ION MODEpyridoxamine1.3197Peak areaFeces Angiotensin II
Reversed phase NEGATIVE ION MODEpyridoxamine1.9154Peak areaFeces Angiotensin II
Reversed phase NEGATIVE ION MODEpyridoxamine1.9850Peak areaFeces Angiotensin II
Reversed phase NEGATIVE ION MODEpyridoxamine2.1419Peak areaFeces Angiotensin II
Reversed phase NEGATIVE ION MODEpyridoxamine2.6504Peak areaFeces Angiotensin II
Reversed phase NEGATIVE ION MODEpyridoxamine2.7657Peak areaFeces Angiotensin II
Reversed phase NEGATIVE ION MODEpyridoxamine2.9393Peak areaFeces Saline
Reversed phase NEGATIVE ION MODEpyridoxamine3.2038Peak areaFeces Saline
Reversed phase NEGATIVE ION MODEpyridoxamine5.7427Peak areaFeces Saline
Reversed phase NEGATIVE ION MODEpyridoxamine7.1275Peak areaFeces Saline
Reversed phase NEGATIVE ION MODEpyridoxamine10.1952Peak areaFeces Saline
Reversed phase NEGATIVE ION MODEpyridoxamine13.1398Peak areaFeces Saline

Return to search page
  logo